DMKPQ
Price:
$0.0001
Market Cap:
$1.01K
DMK Pharmaceuticals Corporation, a clinical stage neuro-biotechnology company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory diseases. The company's lead clinical stage product candidate, DPI-125, which is indicated for the treatment of opioid use disorder. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company was former...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1995-08-14
Stock Exchange
OTC
Ticker
DMKPQ
According to DMK Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current ROE is -209.88%. This represents a change of -218.90% compared to the average of 176.52% of the last 4 quarters.
The mean historical ROE of DMK Pharmaceuticals Corporation over the last ten years is 310.17%. The current -209.88% ROE has changed -167.67% with respect to the historical average. Over the past ten years (40 quarters), DMKPQ's ROE was at its highest in in the December 2022 quarter at 511.33%. The ROE was at its lowest in in the September 2022 quarter at -146.50%.
Average
310.17%
Median
-83.37%
Minimum
-1412.17%
Maximum
4.07%
Discovering the peaks and valleys of DMK Pharmaceuticals Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.59%
Maximum Annual ROE = 4.07%
Minimum Annual Increase = -2397.97%
Minimum Annual ROE = -1412.17%
| Year | ROE | Change |
|---|---|---|
| 2022 | 4.07% | -2397.97% |
| 2021 | -177.06% | -87.46% |
| 2020 | -1412.17% | 1.59% |
| 2019 | -83.37% | -0.21% |
| 2018 | -83.54% | 29.36% |
| 2017 | -64.58% | -16.01% |
The current ROE of DMK Pharmaceuticals Corporation (DMKPQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
826.52%
5-year avg
462.53%
10-year avg
310.17%
DMK Pharmaceuticals Corporation’s ROE is greater than IMV Inc. (-489.29%), less than BioELife Corp. (170.28%), greater than Millennium Sustainable Ventures Corp. (-130.60%), less than eFFECTOR Therapeutics, Inc. (3.77%), less than HLK Biotech Holding Group, Inc. (0%), greater than ContraFect Corporation (-347.26%), greater than BIMI International Medical Inc. (-293.85%), greater than Minerva Surgical, Inc. (-111.32%), less than American Medical Technologies Inc. (135.68%), less than Omnimmune Holdings, Inc. (38.41%),
| Company | ROE | Market cap |
|---|---|---|
| -489.29% | $117.00 | |
| 170.28% | $1.88K | |
| -130.60% | $2.26K | |
| 3.77% | $941.00 | |
| 0% | $925.00 | |
| -347.26% | $1.07K | |
| -293.85% | $1.16K | |
| -111.32% | $8.88K | |
| 135.68% | $1.03K | |
| 38.41% | $981.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DMK Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DMK Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is DMK Pharmaceuticals Corporation's ROE?
How is the ROE calculated for DMK Pharmaceuticals Corporation (DMKPQ)?
What is the highest ROE for DMK Pharmaceuticals Corporation (DMKPQ)?
What is the 3-year average ROE for DMK Pharmaceuticals Corporation (DMKPQ)?
What is the 5-year average ROE for DMK Pharmaceuticals Corporation (DMKPQ)?
How does the current ROE for DMK Pharmaceuticals Corporation (DMKPQ) compare to its historical average?